Learn faster with bite‑sized practice that actually sticks.

Direction in ion delivery (like iontophoresis) isn’t just about “positive goes one way, negative goes the other.” It’s also about who actually carries the electrical current—because who carries the current largely determines what gets delivered.

Let’s walk through it step-by-step, in plain language.

---

1) One current… but many ion “couriers”

When you apply an electric current through a liquid (or a gel), that current doesn’t belong to your drug alone.

Instead, multiple ions share the job of carrying charge through the formulation.

Think of the electric current like a moving walkway at the airport. The walkway’s speed is the current, but lots of travelers (ions) can ride it:

• Your drug ion (the one you want to move)
• Counterions that came with the drug salt (e.g., chloride, sodium)
• Ions from buffers (phosphate, citrate, etc.)
• Ions from added salts (NaCl, etc.)
• Even ions from water splitting at electrodes (in some setups)

So yes, directionality sets the preferred direction for a charged drug—but delivery efficiency depends on whether your drug is a main courier or just one courier among many.

---

2) “Competing ions” and the idea of a transference number (no heavy math)

Here’s the key idea:

The fraction of the total current carried by your drug ion determines how much of the electrical “push” your drug actually gets.

That fraction is often described conceptually as the drug’s transference number.

• If the drug carries a big fraction of the current → it gets a bigger share of the transport → higher delivery for the same applied current.
• If lots of other ions are present and mobile → they carry more of the current → your drug carries a smaller fraction → lower delivery.

Why do background electrolytes reduce drug’s share?

• They can be more concentrated than the drug.
• They can be more mobile (small ions like Na⁺ and Cl⁻ move easily).
• They provide many alternative charge carriers, so the system doesn’t “need” the drug to conduct.

A useful mental picture:

No villain here—just physics: current must be carried by something, and the most available/movable ions tend to do most of the work.

---

3) Faraday’s law, qualitatively: current × time sets the ceiling

Faraday’s law links electrical charge passed to the maximum amount of charged material that could be moved.

In friendly terms:

• More current = more charge per second flowing.
• More time = more total charge delivered.
• So current × time sets an upper limit on how much ionic “stuff” can be transported.

If your drug carried all the current, then the delivered amount would be close to that theoretical maximum.

But in real life:

Only the fraction of current carried by the drug contributes to drug delivery.

So you can think of drug delivery as:

• Maximum possible (set by current and time)
• multiplied by “how much of the current the drug actually gets” (the conceptual transference number)

This is why two formulations run at the same current for the same time can deliver very different drug amounts.

---

4) Ionic strength & added salts: how they unintentionally “steal” current

Ionic strength is basically a measure of how many charged particles are floating around in the formulation.

When ionic strength is high (because of added salts, buffers, etc.):

• There are more non-drug ions available to carry current.
• Small ions often move efficiently, so they become the preferred “couriers.”
• The drug’s transference number usually drops.

So even though the current is the same on your device, the drug may receive a smaller share of the electrical push.

This is the classic surprise:

“I kept the current constant—why did drug delivery drop?”

Often the answer is: because you increased the number of competitor ions.

---

A concrete example: low-salt vs high-salt formulation (same current, same time)

Imagine a positively charged drug, Drug⁺, delivered from the anode.

Formulation A: Low-salt

• Drug⁺ at a useful concentration
• Minimal extra ions (just enough to stabilize pH/solubility)

What happens?

• Fewer competitors.
• Drug⁺ carries a larger fraction of the current.
• Higher delivered flux (more Drug⁺ crosses per unit time).

Formulation B: High-salt (e.g., Drug⁺ plus lots of NaCl)

• Same Drug⁺ concentration
• But now a big population of Na⁺ and Cl⁻ is present

What happens?

• Many more ions are available to conduct.
• Even though Na⁺ is also positive and moves in the same general direction as Drug⁺, it competes to carry the current.
• Drug⁺ now carries a smaller fraction of the total current.
• Lower delivered flux of Drug⁺, even though the device current and treatment time didn’t change.

So the difference isn’t that the electric field “stopped working.” It’s that the field is now busy moving other ions too.

---

Putting it all together (the big picture)

• Directionality tells you which way your drug wants to go.
• Multiple ions share the current, so your drug is competing for “current budget.”
• The transference number (conceptually) is your drug’s share of that budget.
• Current × time sets the maximum delivery ceiling (Faraday’s-law flavor).
• Higher ionic strength / added salts often reduce the drug’s share—so salts can quietly “steal” current and cut delivery.

---

Takeaway

If you want efficient electrically driven delivery, don’t just ask “Is my drug charged?”

Also ask:

“In this formulation, will my drug be a main courier of current—or will it get crowded out by faster, more abundant ions?”

That one question explains a huge chunk of why formulations that look similar on paper can deliver very differently in practice.